Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
Introduction: Among the causes of de novo diagnosed cardiomyopathy, Takotsubo cardiomyopathy (TTC) plays a minor role, with an occurrence of 50,000–100,000 cases per annum in the United States. In clinical practice, a differentiation of a TTC toward an ischemic cardiomyopathy (ICMP) or a dilatative...
Main Authors: | Albert Topf, Moritz Mirna, Nina Bacher, Vera Paar, Lukas J. Motloch, Bernhard Ohnewein, Robert Larbig, Janine Grueninger, Uta C. Hoppe, Michael Lichtenauer, Rudin Pistulli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.700169/full |
Similar Items
-
Endocrinological abnormalities and Takotsubo cardiomyopathy
by: Anu Anna George, et al.
Published: (2021-04-01) -
Stress Cardiomyopathy (Takotsubo Cardiomyopathy)
by: S. S. Yashin, et al.
Published: (2023-03-01) -
Takotsubo Cardiomyopathy: Current Treatment
by: John E. Madias
Published: (2021-08-01) -
Takotsubo Cardiomyopathy With Pheochromocytoma
by: Vikram Agarwal, MD, MPH
Published: (2019-08-01) -
Recurrence of Takotsubo Cardiomyopathy
by: Ken Kato, et al.
Published: (2016-01-01)